Stock Research for BAYZF

BAYZF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BAYZF Stock Chart & Research Data

The BAYZF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BAYZF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BAYZF Due diligence Resources & Stock Charts

The BAYZF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BAYZF Detailed Price Forecast - CNN Money CNN View BAYZF Detailed Summary - Google Finance
Yahoo View BAYZF Detailed Summary - Yahoo! Finance Zacks View BAYZF Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View BAYZF Trends & Analysis - Trade-Ideas Barrons View BAYZF Major Holders - Barrons
NASDAQ View BAYZF Call Transcripts - NASDAQ Seeking View BAYZF Breaking News & Analysis - Seeking Alpha
Spotlight View BAYZF Annual Report - CompanySpotlight.com OTC Report View BAYZF OTC Short Report - OTCShortReport.com
TradeKing View BAYZF Fundamentals - TradeKing Charts View BAYZF SEC Filings - Bar Chart
WSJ View Historical Prices for BAYZF - The WSJ Morningstar View Performance/Total Return for BAYZF - Morningstar
MarketWatch View the Analyst Estimates for BAYZF - MarketWatch CNBC View the Earnings History for BAYZF - CNBC
StockMarketWatch View the BAYZF Earnings - StockMarketWatch MacroAxis View BAYZF Buy or Sell Recommendations - MacroAxis
Bullish View the BAYZF Bullish Patterns - American Bulls Short Pains View BAYZF Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View BAYZF Stock Mentions - StockTwits PennyStocks View BAYZF Stock Mentions - PennyStockTweets
Twitter View BAYZF Stock Mentions - Twitter Invest Hub View BAYZF Investment Forum News - Investor Hub
Yahoo View BAYZF Stock Mentions - Yahoo! Message Board Seeking Alpha View BAYZF Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for BAYZF - SECform4.com Insider Cow View Insider Transactions for BAYZF - Insider Cow
CNBC View BAYZF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BAYZF - OTC Markets
Yahoo View Insider Transactions for BAYZF - Yahoo! Finance NASDAQ View Institutional Holdings for BAYZF - NASDAQ


Stock Charts

FinViz View BAYZF Stock Insight & Charts - FinViz.com StockCharts View BAYZF Investment Charts - StockCharts.com
BarChart View BAYZF Stock Overview & Charts - BarChart Trading View View BAYZF User Generated Charts - Trading View


Latest Financial News for BAYZF

Lenvima’s Approval in Japan Is Expected to Drive Merck’s Growth
Posted on Friday May 25, 2018

In March, Merck & Company (MRK) and Eisai announced that Lenvima had received approval in Japan for the treatment of individuals with unresectable hepatocellular carcinoma (or HCC). Globally, Lenvima’s approval for the treatment of HCC in Japan became its first approval worldwide for the treatment of unresectable HCC.


Bayer to Win Antitrust Approval for Monsanto Bid
Posted on Friday May 25, 2018

Bayer will win antitrust approval for its $66 billion takeover of Monsanto next week, sources say #tictocnews https://bloom.bg/2s6Ndkg (Source: Bloomberg)


Bayer cuts Monsanto synergy target by $300 million due to divestments
Posted on Friday May 25, 2018

Bayer said positive synergy effects from the planned takeover of U.S. seeds maker Monsanto would be about $300 million below its previous target because it will sell more businesses than initially expected to get antitrust approval. Bayer Chief Executive Werner Baumann again threw his weight behind the deal, despite higher antitrust hurdles and delays in the regulatory reviews, speaking to shareholders at the annual general meeting on Friday. "I'm convinced that this acquisition has very great potential for creating value for our company, our stockholders and our customers," Baumann said, adding he expected the deal to be approved and closed in the near future.


Bayer to Win U.S. Antitrust Nod for Monsanto Deal Next Week
Posted on Friday May 25, 2018

Bayer AG is set to win U.S. antitrust approval for its $66 billion takeover of Monsanto Co. by next week, according to a person familiar with the matter, removing the last major regulatory hurdle to forming the world’s biggest seed and agricultural-chemicals company. The companies and the Justice Department have negotiated a complex agreement that would resolve the government’s concerns that the merger as initially structured would harm competition, said the person, who asked not to be named because the matter is private. The German company’s agreement to buy Monsanto, announced two years ago, is one of several deals involving seed and crop-chemical firms around the world.


Enter a stock symbol to view the stock details.